Levamlodipine (besylate Hemipentahydrate)

Levamlodipine besylate hemipentahydrate is the besylate hemipentahydrate salt form of Levamlodipine (HY-14744) . Levamlodipine besylate hemipentahydrate is an orally active calcium channel blocker with antioxidant and vasodilatory properties. Levamlodipine besylate hemipentahydrate can reduce serum malondialdehyde (MDA) levels, increase superoxide dismutase (SOD) activity, and improve oxidative stress. Levamlodipine besylate hemipentahydrate can be used for research on vascular dementia, hypertension, and cerebrovascular diseases[1][2][3][4].

Product Specifications

CAS Number

[884648-62-8]

UNSPSC

12352005

Target

Calcium Channel; SOD

Related Pathways

Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling

Field of Research

Neurological Disease; Cardiovascular Disease

Smiles

O=S(O)(C1=CC=CC=C1)=O.O=C(C2=C(COCCN)NC(C)=C(C(OC)=O)[C@@H]2C3=CC=CC=C3Cl)OCC.O.[2.5]

Molecular Formula

C20H25ClN2O5.C6H6O3S.5/2H2O

Molecular Weight

1224.18

References & Citations

[1]Yao KX, et al. Effect of low-dose Levamlodipine Besylate in the treatment of vascular dementia. Sci Rep. 2019 Dec 3;9 (1) :18248. |[2]Rong H, et al. [Effect of probucol on serum malondialdehyde and superoxide dismutase in patients with primary hypertension]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 May;37 (5) :458-62. |[3]Yang YL, et al. Synergic effects of levamlodipine and bisoprolol on blood pressure reduction and organ protection in spontaneously hypertensive rats. CNS Neurosci Ther. 2012 Jun;18 (6) :471-4. |[4]Lee YJ, et al. Amlodipine besylate and amlodipine camsylate prevent cortical neuronal cell death induced by oxidative stress. J Neurochem. 2011 Dec;119 (6) :1262-70.